APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nedaplatin Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nedaplatin Injection Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchNedaplatin Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nedaplatin Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Nedaplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nedaplatin Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nedaplatin Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nedaplatin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nedaplatin Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nedaplatin Injection market include Nichi-Iko Pharmaceutical, Jilin Hengjin Pharmaceutical, Aosaikang Pharma, Simcere and Qilu Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nedaplatin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nedaplatin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nedaplatin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nedaplatin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Nedaplatin Injection Segment by Company

Nichi-Iko Pharmaceutical

Jilin Hengjin Pharmaceutical

Aosaikang Pharma

Simcere

Qilu Pharma

Nedaplatin Injection Segment by Type

10mg

50mg

100mg

Nedaplatin Injection Segment by Application

Cervical Cancer

Esophageal Cancer

Ovarian Cancer

Testicular Cancer

Lung Cancer

Bladder Cancer

Other

Nedaplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nedaplatin Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nedaplatin Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nedaplatin Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Nedaplatin Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nedaplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nedaplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nedaplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nedaplatin Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nedaplatin Injection industry.

Chapter 3: Detailed analysis of Nedaplatin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nedaplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nedaplatin Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nedaplatin Injection Industry Trends Table 2. Nedaplatin Injection Industry Drivers Table 3. Nedaplatin Injection Industry Opportunities and Challenges Table 4. Nedaplatin Injection Industry Restraints Table 5. Global Nedaplatin Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nedaplatin Injection Revenue Share by Company (2021-2026) Table 7. Global Nedaplatin Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nedaplatin Injection Sales Volume Share by Company (2021-2026) Table 9. Global Nedaplatin Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nedaplatin Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nedaplatin Injection Key Company Manufacturing Base & Headquarters Table 12. Global Nedaplatin Injection Company, Product Type & Application Table 13. Global Nedaplatin Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nedaplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of 100mg Table 20. Global Nedaplatin Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Nedaplatin Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Nedaplatin Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Nedaplatin Injection Sales Volume Share by Type (2021-2026) Table 24. Global Nedaplatin Injection Sales Volume Share by Type (2027-2032) Table 25. Global Nedaplatin Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nedaplatin Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nedaplatin Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nedaplatin Injection Sales Value Share by Type (2021-2026) Table 29. Global Nedaplatin Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cervical Cancer Table 31. Significant Companies of Esophageal Cancer Table 32. Significant Companies of Ovarian Cancer Table 33. Significant Companies of Testicular Cancer Table 34. Significant Companies of Lung Cancer Table 35. Significant Companies of Bladder Cancer Table 36. Significant Companies of Other Table 37. Global Nedaplatin Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Nedaplatin Injection Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Nedaplatin Injection Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Nedaplatin Injection Sales Volume Share by Application (2021-2026) Table 41. Global Nedaplatin Injection Sales Volume Share by Application (2027-2032) Table 42. Global Nedaplatin Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Nedaplatin Injection Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Nedaplatin Injection Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Nedaplatin Injection Sales Value Share by Application (2021-2026) Table 46. Global Nedaplatin Injection Sales Value Share by Application (2027-2032) Table 47. Global Nedaplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Nedaplatin Injection Sales by Region (2021-2026) & (K Units) Table 49. Global Nedaplatin Injection Sales Market Share by Region (2021-2026) Table 50. Global Nedaplatin Injection Sales by Region (2027-2032) & (K Units) Table 51. Global Nedaplatin Injection Sales Market Share by Region (2027-2032) Table 52. Global Nedaplatin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Nedaplatin Injection Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Nedaplatin Injection Sales Value Share by Region (2021-2026) Table 55. Global Nedaplatin Injection Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Nedaplatin Injection Sales Value Share by Region (2027-2032) Table 57. Global Nedaplatin Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Nedaplatin Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Nedaplatin Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 62. Global Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 63. Global Nedaplatin Injection Sales by Country (2027-2032) & (K Units) Table 64. Global Nedaplatin Injection Sales Market Share by Country (2027-2032) Table 65. Global Nedaplatin Injection Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Nedaplatin Injection Sales Value Market Share by Country (2021-2026) Table 67. Global Nedaplatin Injection Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Nedaplatin Injection Sales Value Market Share by Country (2027-2032) Table 69. Nichi-Iko Pharmaceutical Company Information Table 70. Nichi-Iko Pharmaceutical Business Overview Table 71. Nichi-Iko Pharmaceutical Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio Table 73. Nichi-Iko Pharmaceutical Recent Development Table 74. Jilin Hengjin Pharmaceutical Company Information Table 75. Jilin Hengjin Pharmaceutical Business Overview Table 76. Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio Table 78. Jilin Hengjin Pharmaceutical Recent Development Table 79. Aosaikang Pharma Company Information Table 80. Aosaikang Pharma Business Overview Table 81. Aosaikang Pharma Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Aosaikang Pharma Nedaplatin Injection Product Portfolio Table 83. Aosaikang Pharma Recent Development Table 84. Simcere Company Information Table 85. Simcere Business Overview Table 86. Simcere Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Simcere Nedaplatin Injection Product Portfolio Table 88. Simcere Recent Development Table 89. Qilu Pharma Company Information Table 90. Qilu Pharma Business Overview Table 91. Qilu Pharma Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Qilu Pharma Nedaplatin Injection Product Portfolio Table 93. Qilu Pharma Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Nedaplatin Injection Distributors List Table 97. Nedaplatin Injection Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Nedaplatin Injection Product Image Figure 2. Global Nedaplatin Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nedaplatin Injection Sales (2021-2032) & (K Units) Figure 5. Global Nedaplatin Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nedaplatin Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg Image Figure 10. 50mg Image Figure 11. 100mg Image Figure 12. Global Nedaplatin Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Nedaplatin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nedaplatin Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Nedaplatin Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nedaplatin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nedaplatin Injection Sales Value Share by Type (2021-2032) Figure 18. Cervical Cancer Image Figure 19. Esophageal Cancer Image Figure 20. Ovarian Cancer Image Figure 21. Testicular Cancer Image Figure 22. Lung Cancer Image Figure 23. Bladder Cancer Image Figure 24. Other Image Figure 25. Global Nedaplatin Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Nedaplatin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Nedaplatin Injection Sales Volume Share by Application (2021-2032) Figure 28. Global Nedaplatin Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nedaplatin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Nedaplatin Injection Sales Value Share by Application (2021-2032) Figure 31. Global Nedaplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Nedaplatin Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Nedaplatin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Nedaplatin Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 36. North America Nedaplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Nedaplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Nedaplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 42. South America Nedaplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Nedaplatin Injection Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Nedaplatin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Nedaplatin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Nedaplatin Injection Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Nedaplatin Injection Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 50mg
  • 100mg
Applications
  • Cervical Cancer
  • Esophageal Cancer
  • Ovarian Cancer
  • Testicular Cancer
  • Lung Cancer
  • Bladder Cancer
  • Other
Companies covered
  • Nichi-Iko Pharmaceutical
  • Jilin Hengjin Pharmaceutical
  • Aosaikang Pharma
  • Simcere
  • Qilu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nedaplatin Injection Sales Value (2021-2032)
  4. 1.2.2 Global Nedaplatin Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Nedaplatin Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nedaplatin Injection Market Dynamics
  1. 2.1 Nedaplatin Injection Industry Trends
  2. 2.2 Nedaplatin Injection Industry Drivers
  3. 2.3 Nedaplatin Injection Industry Opportunities and Challenges
  4. 2.4 Nedaplatin Injection Industry Restraints
3 Nedaplatin Injection Market by Company
  1. 3.1 Global Nedaplatin Injection Company Revenue Ranking in 2025
  2. 3.2 Global Nedaplatin Injection Revenue by Company (2021-2026)
  3. 3.3 Global Nedaplatin Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Nedaplatin Injection Average Price by Company (2021-2026)
  5. 3.5 Global Nedaplatin Injection Company Ranking (2024-2026)
  6. 3.6 Global Nedaplatin Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Nedaplatin Injection Company Product Type and Application
  8. 3.8 Global Nedaplatin Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nedaplatin Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nedaplatin Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nedaplatin Injection Market by Type
  1. 4.1 Nedaplatin Injection Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 50mg
  4. 4.1.3 100mg
  5. 4.2 Global Nedaplatin Injection Sales Volume by Type
  6. 4.2.1 Global Nedaplatin Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nedaplatin Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nedaplatin Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nedaplatin Injection Sales Value by Type
  10. 4.3.1 Global Nedaplatin Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nedaplatin Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nedaplatin Injection Sales Value Share by Type (2021-2032)
5 Nedaplatin Injection Market by Application
  1. 5.1 Nedaplatin Injection Application Introduction
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Esophageal Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Testicular Cancer
  6. 5.1.5 Lung Cancer
  7. 5.1.6 Bladder Cancer
  8. 5.1.7 Other
  9. 5.2 Global Nedaplatin Injection Sales Volume by Application
  10. 5.2.1 Global Nedaplatin Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Nedaplatin Injection Sales Volume by Application (2021-2032)
  12. 5.2.3 Global Nedaplatin Injection Sales Volume Share by Application (2021-2032)
  13. 5.3 Global Nedaplatin Injection Sales Value by Application
  14. 5.3.1 Global Nedaplatin Injection Sales Value by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Nedaplatin Injection Sales Value by Application (2021-2032)
  16. 5.3.3 Global Nedaplatin Injection Sales Value Share by Application (2021-2032)
6 Nedaplatin Injection Regional Sales and Value Analysis
  1. 6.1 Global Nedaplatin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nedaplatin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Nedaplatin Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Nedaplatin Injection Sales by Region (2027-2032)
  5. 6.3 Global Nedaplatin Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nedaplatin Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nedaplatin Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nedaplatin Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Nedaplatin Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nedaplatin Injection Sales Value (2021-2032)
  12. 6.6.2 North America Nedaplatin Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nedaplatin Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Nedaplatin Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nedaplatin Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nedaplatin Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nedaplatin Injection Sales Value (2021-2032)
  21. 6.9.2 South America Nedaplatin Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nedaplatin Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nedaplatin Injection Sales Value Share by Country, 2025 VS 2032
7 Nedaplatin Injection Country-level Sales and Value Analysis
  1. 7.1 Global Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nedaplatin Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nedaplatin Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Nedaplatin Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Nedaplatin Injection Sales by Country (2027-2032)
  6. 7.4 Global Nedaplatin Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nedaplatin Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nedaplatin Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nedaplatin Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nedaplatin Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nedaplatin Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nichi-Iko Pharmaceutical
  2. 8.1.1 Nichi-Iko Pharmaceutical Company Information
  3. 8.1.2 Nichi-Iko Pharmaceutical Business Overview
  4. 8.1.3 Nichi-Iko Pharmaceutical Nedaplatin Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio
  6. 8.1.5 Nichi-Iko Pharmaceutical Recent Developments
  7. 8.2 Jilin Hengjin Pharmaceutical
  8. 8.2.1 Jilin Hengjin Pharmaceutical Company Information
  9. 8.2.2 Jilin Hengjin Pharmaceutical Business Overview
  10. 8.2.3 Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio
  12. 8.2.5 Jilin Hengjin Pharmaceutical Recent Developments
  13. 8.3 Aosaikang Pharma
  14. 8.3.1 Aosaikang Pharma Company Information
  15. 8.3.2 Aosaikang Pharma Business Overview
  16. 8.3.3 Aosaikang Pharma Nedaplatin Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Aosaikang Pharma Nedaplatin Injection Product Portfolio
  18. 8.3.5 Aosaikang Pharma Recent Developments
  19. 8.4 Simcere
  20. 8.4.1 Simcere Company Information
  21. 8.4.2 Simcere Business Overview
  22. 8.4.3 Simcere Nedaplatin Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Simcere Nedaplatin Injection Product Portfolio
  24. 8.4.5 Simcere Recent Developments
  25. 8.5 Qilu Pharma
  26. 8.5.1 Qilu Pharma Company Information
  27. 8.5.2 Qilu Pharma Business Overview
  28. 8.5.3 Qilu Pharma Nedaplatin Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharma Nedaplatin Injection Product Portfolio
  30. 8.5.5 Qilu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nedaplatin Injection Value Chain Analysis
  2. 9.1.1 Nedaplatin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nedaplatin Injection Sales Mode & Process
  6. 9.2 Nedaplatin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nedaplatin Injection Distributors
  9. 9.2.3 Nedaplatin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst